Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with CAPOX-RT in Rectal Cancer
NCT00795301Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jul 2008
- Primary completion
- Dec 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in rectal cancer, sponsored by National University Hospital. Status: unknown.
02
Drugs
cetuximab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00795301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795301.